Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Respiratory Tract Infections × Ribavirin × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hepatitis C 2 Carcinoma, Hepatocellular 2 Respiratory Tract Infections 1 Respiratory Syncytial Virus Infections 1 Recurrence 1 Pneumonia 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hepatitis 1 Bronchiolitis Obliterans Syndrome 1

Interventions

tocilizumab 1 Ribavirin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

M.D. Anderson Cancer Center

Phase 2 Completed

48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡